Recall Radar
All recallsMedicine & devices

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC…

Lack of assurance of Sterility:

Class II Medicine & devices FDA July 8, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
ACCORD BIOPHARMA INC — Raleigh, NC
Severity
Class II — moderate
Reported
July 8, 2026
Quantity
326 vials
Recall number
D-0653-2026
Status
Ongoing
Source
FDA

Where it went

US Nationwide.

Other medicine & devices recalls

See every current recall on the live dashboard →